FDA Approved: EVOMELA — Supplemental Application (Acrotech Biopharma Inc)

View source ↗

Summary

FDA approved a supplemental application for EVOMELA (melphalan liposome injection) filed by Acrotech Biopharma Inc., updating the product labeling and/or indica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• EVOMELA (melphalan hydrochloride)

Snippet

SUPPL AP for EVOMELA (MELPHALAN)